Page last updated: 2024-09-03

7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone and Bronchopulmonary Dysplasia

7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone has been researched along with Bronchopulmonary Dysplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, M; Bejjani, BA; Bhatt, SS; Bolivar, J; Carter, NP; Cheung, SW; Driscoll, DJ; Durham-O'Donnell, J; Fitzgerald, T; Gribble, S; Hallam, L; Hustead, V; Kini, U; Knight, G; Langston, C; Maisenbacher, MK; Martin, V; Mascotti, K; McDonald-McGinn, D; McRae, D; Mehta, S; Murray, M; Newbury, R; Nicholson, AG; Nowaczyk, MM; Ou, Z; Patel, A; Paterson, J; Prigmore, E; Rajan, D; Schultz, R; Sen, P; Shaffer, LG; Shaikh, TH; Shaw-Smith, C; Simonic, I; Stankiewicz, P; Storer, M; Tyreman, M; Willatt, L; Wiszniewska, J; Xia, Z; Zackai, EH1

Other Studies

1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone and Bronchopulmonary Dysplasia

ArticleYear
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations.
    American journal of human genetics, 2009, Volume: 84, Issue:6

    Topics: Abnormalities, Multiple; Bronchopulmonary Dysplasia; Capillaries; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 16; Doxorubicin; Female; Forkhead Transcription Factors; Gene Deletion; Gene Silencing; Humans; In Situ Hybridization, Fluorescence; Infant; Infant, Newborn; Male; Mutation; Pulmonary Alveoli; Pulmonary Veins

2009